tiprankstipranks
BrainStorm announces agreement with FDA on SPA for Phase 3b ALS trial
PremiumThe FlyBrainStorm announces agreement with FDA on SPA for Phase 3b ALS trial
10d ago
BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
18d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
28d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
BrainStorm granted patents for allogeneic exosome platform-product
PremiumThe Fly
BrainStorm granted patents for allogeneic exosome platform-product
4M ago
Brainstorm Cell Therapeutics (NASDAQ:BCLI) to Meet with FDA for New Treatment Plans
PremiumMarket NewsBrainstorm Cell Therapeutics (NASDAQ:BCLI) to Meet with FDA for New Treatment Plans
5M ago
BrainStorm granted in-person meeting with the FDA for Phase 3 ALS trial
PremiumThe Fly
BrainStorm granted in-person meeting with the FDA for Phase 3 ALS trial
5M ago
BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100